Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients

AIMS: Fingolimod, an orally active immunomodulatory drug for relapsing‐remitting multiple sclerosis (RRMS), sequesters T cells in lymph nodes through functional antagonism of the sphingosine‐1‐phosphate receptor, reducing the number of potential autoreactive cells that migrate to the central nervous...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:CNS Neurosci Ther
Hlavní autoři: Quirant‐Sánchez, Bibiana, Hervás‐García, José V., Teniente‐Serra, Aina, Brieva, Luis, Moral‐Torres, Ester, Cano, Antonio, Munteis, Elvira, Mansilla, María J., Presas‐Rodriguez, Silvia, Navarro‐Barriuso, Juan, Ramo‐Tello, Cristina, Martínez‐Cáceres, Eva M.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489963/
https://ncbi.nlm.nih.gov/pubmed/29656444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12851
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky